In this conversation, Dr. Tiernan Keenan discusses his research on macular degeneration, particularly focusing on the AREDS studies and the upcoming AREDS 3. He shares insights on the effectiveness of supplements in slowing the progression of geographic atrophy and the design considerations for future studies. The discussion also delves into the role of AI in ophthalmology, its potential to enhance clinical decision-making, and the challenges of implementing AI in healthcare. Dr. Keenan emphasizes the importance of understanding the diverse phenotypes of macular degeneration across different populations and the need for more research in this area.

--------------------

For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table!

[email protected]

https://coopervision.com/our-company/news-center/press-release/coopervision-and-aoa-join-forces-launch-myopia-collective

Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts 

Show Sponsors: CooperVision MacuHealth